Barbara Tilley - Publications

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Biostatistics Biology, Public Health, Clinical Psychology

133 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Amorrortu RP, Arevalo M, Vernon SW, Mainous AG, Diaz V, McKee MD, Ford ME, Tilley BC. Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach. Trials. 19: 115. PMID 29454389 DOI: 10.1186/s13063-018-2507-9  0.36
2017 Tilley BC, Mainous AG, Smith DW, McKee MD, Amorrortu RP, Alvidrez J, Diaz V, Ford ME, Fernandez ME, Hauser RA, Singer C, Landa V, Trevino A, DeSantis SM, Zhang Y, et al. Design of a cluster-randomized minority recruitment trial: RECRUIT. Clinical Trials (London, England). 14: 286-298. PMID 28545336 DOI: 10.1177/1740774517690146  0.36
2017 Simon DK, Wu C, Tilley BC, Lohmann K, Klein C, Payami H, Wills AM, Aminoff MJ, Bainbridge J, Dewey R, Hauser RA, Schaake S, Schneider JS, Sharma S, Singer C, et al. Caffeine, creatine, GRIN2A and Parkinson's disease progression. Journal of the Neurological Sciences. 375: 355-359. PMID 28320167 DOI: 10.1016/j.jns.2017.02.032  0.32
2016 Yang C, Ford ME, Tilley BC, Greene RL. Religiosity in black and white older Americans: Measure adaptation, psychometric validation, and racial difference. Medicine. 95: e4257. PMID 27631201 DOI: 10.1097/MD.0000000000004257  0.36
2016 Zhu H, Fox EE, Baraniuk S, Holcomb JB, Wade CE, Del Junco DJ, Tilley BC. Assessing protocol adherence in a clinical trial with ordered treatment regimens: Quantifying the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial experience. Injury. PMID 27476886 DOI: 10.1016/j.injury.2016.07.028  0.32
2016 Thornton LR, Amorrortu RP, Smith DW, Mainous AG, Vernon SW, Tilley BC. Exploring Willingness of Elder Chinese in Houston to Participate in Clinical Research. Contemporary Clinical Trials Communications. 4: 33-38. PMID 27458608 DOI: 10.1016/j.conctc.2016.06.006  0.32
2016 Wallace SK, Rathi NK, Waller DK, Ensor JE, Haque SA, Price KJ, Piller LB, Tilley BC, Nates JL. Two Decades of ICU Utilization and Hospital Outcomes in a Comprehensive Cancer Center. Critical Care Medicine. PMID 26765498 DOI: 10.1097/CCM.0000000000001568  0.32
2015 Yamal JM, Benoit JS, Doshi P, Rubin ML, Tilley BC, Hannay HJ, Robertson CS. Association of transfusion red blood cell storage age and blood oxygenation, long-term neurologic outcome, and mortality in traumatic brain injury. The Journal of Trauma and Acute Care Surgery. 79: 843-9. PMID 26496111 DOI: 10.1097/TA.0000000000000834  0.32
2015 Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS. Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clinical Neuropharmacology. 38: 163-9. PMID 26366971 DOI: 10.1097/WNF.0000000000000102  0.32
2015 Ma J, Chan W, Tsai CL, Xiong M, Tilley BC. Analysis of transtheoretical model of health behavioral changes in a nutrition intervention study-a continuous time Markov chain model with Bayesian approach. Statistics in Medicine. PMID 26123093 DOI: 10.1002/sim.6571  0.32
2015 Wallace SK, Waller DK, Tilley BC, Piller LB, Price KJ, Rathi N, Haque S, Nates JL. Place of Death among Hospitalized Patients with Cancer at the End of Life. Journal of Palliative Medicine. PMID 25927588 DOI: 10.1089/jpm.2014.0389  0.32
2015 Novak DJ, Bai Y, Cooke RK, Marques MB, Fontaine MJ, Gottschall JL, Carey PM, Scanlan RM, Fiebig EW, Shulman IA, Nelson JM, Flax S, Duncan V, Daniel-Johnson JA, Callum JL, ... ... Tilley BC, et al. Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial. Transfusion. 55: 1331-9. PMID 25823522 DOI: 10.1111/trf.13098  0.32
2015 Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, et al. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. Jama. 313: 584-93. PMID 25668262 DOI: 10.1001/jama.2015.120  0.32
2015 Goetz CG, Luo S, Wang L, Tilley BC, LaPelle NR, Stebbins GT. Handling missing values in the MDS-UPDRS. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 25649812 DOI: 10.1002/mds.26153  0.32
2015 Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. Jama. 313: 471-82. PMID 25647203 DOI: 10.1001/jama.2015.12  0.32
2015 Yamal JM, Rubin ML, Benoit JS, Tilley BC, Gopinath S, Hannay HJ, Doshi P, Aisiku IP, Robertson CS. Effect of Hemoglobin Transfusion Threshold on Cerebral Hemodynamics and Oxygenation. Journal of Neurotrauma. PMID 25566694 DOI: 10.1089/neu.2014.3752  0.32
2015 Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, ... ... Tilley BC, et al. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 37-43. PMID 23607783 DOI: 10.1111/ene.12165  0.32
2015 Simuni T, Kieburtz K, Tilley B, J Elm J, Ravina B, Babcock D, Emborg M, Hauser R, Kamp C, Morgan JC, Webster Ross G, K Simon D, Bainbridge J, Baker L, Bodis-Wollner I, et al. Pioglitazone in early Parkinson's disease: A phase 2, multicentre, double-blind, randomised trial The Lancet Neurology. 14: 795-803. DOI: 10.1016/S1474-4422(15)00144-1  0.32
2014 Segal CG, Waller DK, Tilley B, Piller L, Bilimoria K. An evaluation of differences in risk factors for individual types of surgical site infections after colon surgery. Surgery. 156: 1253-60. PMID 25178993 DOI: 10.1016/j.surg.2014.05.010  0.32
2014 Goldman JG, Stebbins GT, Leung V, Tilley BC, Goetz CG. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. Parkinsonism & Related Disorders. 20: 1135-9. PMID 25150770 DOI: 10.1016/j.parkreldis.2014.08.001  0.32
2014 Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, ... ... Tilley B, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet (London, England). 384: 1929-35. PMID 25106063 DOI: 10.1016/S0140-6736(14)60584-5  0.32
2014 Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC, Baldwin A, Rivera Lara L, Saucedo-Crespo H, Ahmed O, Sadasivan S, Ponce L, Cruz-Navarro J, Shahin H, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. Jama. 312: 36-47. PMID 25058216 DOI: 10.1001/jama.2014.6490  0.32
2014 Baraniuk S, Tilley BC, del Junco DJ, Fox EE, van Belle G, Wade CE, Podbielski JM, Beeler AM, Hess JR, Bulger EM, Schreiber MA, Inaba K, Fabian TC, Kerby JD, Cohen MJ, et al. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. Injury. 45: 1287-95. PMID 24996573 DOI: 10.1016/j.injury.2014.06.001  0.32
2014 Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. Jama Neurology. 71: 710-6. PMID 24711047 DOI: 10.1001/jamaneurol.2014.391  0.32
2014 Yamal JM, Robertson CS, Rubin ML, Benoit JS, Hannay HJ, Tilley BC. Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: effect of availability of exception from informed consent. Clinical Trials (London, England). 11: 187-94. PMID 24686108 DOI: 10.1177/1740774514522560  0.32
2014 Martínez-Martín P, Rodríguez-Blázquez C, Forjaz MJ, Alvarez-Sánchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martínez-Castrillo JC, Mendoza-Rodríguez A, Moore HP, Rodríguez-Violante M, Singer C, ... Tilley BC, et al. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 21: 519-24. PMID 24447695 DOI: 10.1111/ene.12349  0.32
2013 Rodriguez-Blazquez C, Rojo-Abuin JM, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, et al. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. Parkinsonism & Related Disorders. 19: 889-93. PMID 23791519 DOI: 10.1016/j.parkreldis.2013.05.017  0.32
2013 Emberson J, Lees KR, Howard G, Bluhmki E, Tilley B, Albers G, Baigent C, Blackwell L, Davis S, Donnan G, Grotta J, Hacke W, Kaste M, von Kummer R, Lansberg M, et al. Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: Statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis International Journal of Stroke. 8: 278-283. PMID 23639145 DOI: 10.1111/ijs.12040  0.32
2013 Ford ME, Siminoff LA, Pickelsimer E, Mainous AG, Smith DW, Diaz VA, Soderstrom LH, Jefferson MS, Tilley BC. Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health & Social Work. 38: 29-38. PMID 23539894 DOI: 10.1093/hsw/hlt001  0.32
2013 Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 668-70. PMID 23408503 DOI: 10.1002/mds.25383  0.32
2013 Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, et al. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Journal of Neurology. 260: 228-36. PMID 22865238 DOI: 10.1007/s00415-012-6624-1  0.32
2013 Antonini A, Abbruzzese G, Ferini-Strambi L, Tilley B, Huang J, Stebbins GT, Goetz CG, Barone P, Bandettini di Poggio M, Fabbrini G, Di Stasio F, Tinazzi M, Bovi T, Ramat S, et al. Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 34: 683-7. PMID 22678179 DOI: 10.1007/s10072-012-1112-z  0.32
2013 Škorvánek M, Košutzká Z, Valkoviè P, Ghorbani Saeedian R, Gdovinová Z, La Pelle N, Huang J, Tilley BC, Stebbins GT, Goetz CG. Validation of the Slovak version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Ceska a Slovenska Neurologie a Neurochirurgie. 76: 463-468.  0.32
2012 Yang C, Selassie AW, Carter RE, Tilley BC. Measuring Quality of Life with SF-36 in Older Americans with Traumatic Brain Injury. Applied Research in Quality of Life. 7: 63-81. PMID 25411585 DOI: 10.1007/s11482-011-9148-4  0.32
2012 Brown RT, Shaftman SR, Tilley BC, Anthony KK, Kral MC, Maxson B, Mee L, Bonner MJ, Vogler LB, Schanberg LE, Connelly MA, Wagner JL, Silver RM, Nietert PJ. The health education for lupus study: a randomized controlled cognitive-behavioral intervention targeting psychosocial adjustment and quality of life in adolescent females with systemic lupus erythematosus. The American Journal of the Medical Sciences. 344: 274-82. PMID 22996139 DOI: 10.1097/MAJ.0b013e3182449be9  0.32
2012 Goetz CG, Stebbins GT, Tilley BC. Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1239-42. PMID 22886777 DOI: 10.1002/mds.25122  0.32
2012 Voss TS, Elm JJ, Wielinski CL, Aminoff MJ, Bandyopadhyay D, Chou KL, Sudarsky LR, Tilley BC. Fall frequency and risk assessment in early Parkinson's disease. Parkinsonism & Related Disorders. 18: 837-41. PMID 22542094 DOI: 10.1016/j.parkreldis.2012.04.004  0.32
2012 Tilley BC, Mainous AG, Elm JJ, Pickelsimer E, Soderstrom LH, Ford ME, Diaz VA, Siminoff LA, Burau K, Smith DW. A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy. Clinical Trials (London, England). 9: 188-97. PMID 22496398 DOI: 10.1177/1740774512436881  0.32
2012 Blajchman MA, Carson JL, Eikelboom J, Heddle NM, Lacroix J, Lauer MS, Platt R, Tilley B, Triulzi D, Vickers AJ, Yusuf S, Glynn S, Mondoro TH. The role of comparative effectiveness research in transfusion medicine clinical trials: Proceedings of a National Heart, Lung, and Blood Institute workshop Transfusion. 52: 1363-1378. PMID 22486525 DOI: 10.1111/j.1537-2995.2012.03640.x  0.32
2012 Tilley BC. Contemporary outcome measures in acute stroke research: choice of primary outcome measure and statistical analysis of the primary outcome in acute stroke trials. Stroke; a Journal of Cerebral Circulation. 43: 935-7. PMID 22426318 DOI: 10.1161/STROKEAHA.111.644864  0.32
2012 Simpson KN, Tilley BC. Economic analysis of secondary trial data. Progress in Cardiovascular Diseases. 54: 351-6. PMID 22226003 DOI: 10.1016/j.pcad.2011.08.004  0.32
2012 Tilley BC, Davis BR. Secondary analyses in cardiovascular clinical trials - statistical and other considerations. Introduction. Progress in Cardiovascular Diseases. 54: 329. PMID 22225998 DOI: 10.1016/j.pcad.2011.11.003  0.32
2012 Goetz CG, Tilley BC, Stebbins GT. Dopamine dysregulation syndrome item from the MDS-UPDRS. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 166. PMID 22025291 DOI: 10.1002/mds.23910  0.32
2012 Seidel SE, Tilley BC, Huang P, Palesch YY, Bergmann KJ, Goetz CG, Swearingen CJ. Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale. Parkinsonism & Related Disorders. 18: 230-3. PMID 22018910 DOI: 10.1016/j.parkreldis.2011.10.006  0.32
2011 Gressens P, Le Verche V, Fraser M, Rousset CI, Schwendimann L, Bennet L, George SA, Wang X, Mallard C, Tilley BC, Dournaud P, Gunn AJ, Hagberg H, Levison SW. Pitfalls in the quest of neuroprotectants for the perinatal brain. Developmental Neuroscience. 33: 189-98. PMID 21968048 DOI: 10.1159/000333109  0.32
2011 Swearingen CJ, Tilley BC, Adams RJ, Rumboldt Z, Nicholas JS, Bandyopadhyay D, Woolson RF. Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials. Neuroepidemiology. 37: 73-82. PMID 21894044 DOI: 10.1159/000330375  0.32
2011 Tilley BC, Palesch YY. Conduct of Stroke-Related Clinical Trials Stroke. 1192-1203. DOI: 10.1016/B978-1-4160-5478-8.10060-0  0.32
2010 Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2704-16. PMID 20931631 DOI: 10.1002/mds.23190  0.32
2010 McQueen A, Vernon SW, Rothman AJ, Norman GJ, Myers RE, Tilley BC. Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 40: 205-17. PMID 20658212 DOI: 10.1007/s12160-010-9215-3  0.32
2010 Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 375: 1695-703. PMID 20472172 DOI: 10.1016/S0140-6736(10)60491-6  0.32
2010 Elble RJ, Suchowersky O, Shaftman S, Weiner WJ, Huang P, Tilley B. Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1082-6. PMID 20131372 DOI: 10.1002/mds.22997  0.32
2009 Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Archives of Neurology. 66: 1099-104. PMID 19597081 DOI: 10.1001/archneurol.2009.159  0.32
2009 Magruder KM, Bichun Ouyang, Miller S, Tilley BC. Retention of under-represented minorities in drug abuse treatment studies. Clinical Trials (London, England). 6: 252-60. PMID 19528134 DOI: 10.1177/1740774509105224  0.32
2009 Huang P, Goetz CG, Woolson RF, Tilley B, Kerr D, Palesch Y, Elm J, Ravina B, Bergmann KJ, Kieburtz K. Using global statistical tests in long-term Parkinson's disease clinical trials. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1732-9. PMID 19514076 DOI: 10.1002/mds.22645  0.32
2009 Rajamani K, Chaturvedi S, Jin Z, Homma S, Brey RL, Tilley BC, Sacco RL, Thompson JL, Mohr JP, Levine SR. Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke; a Journal of Cerebral Circulation. 40: 2337-42. PMID 19498198 DOI: 10.1161/STROKEAHA.108.539171  0.32
2009 Yang C, Garrett-Mayer E, Schneider JS, Gollomp SM, Tilley BC. Repeatable battery for assessment of neuropsychological status in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1453-60. PMID 19452561 DOI: 10.1002/mds.22552  0.32
2009 Nietert PJ, Tilley BC, Zhao W, Edwards PF, Wessell AM, Mauldin PD, Polk PP. Two pharmacy interventions to improve refill persistence for chronic disease medications: a randomized, controlled trial. Medical Care. 47: 32-40. PMID 19106728 DOI: 10.1097/MLR.0b013e3181808c17  0.32
2009 Schneider MG, Swearingen CJ, Shulman LM, Ye J, Baumgarten M, Tilley BC. Minority enrollment in Parkinson's disease clinical trials. Parkinsonism & Related Disorders. 15: 258-62. PMID 18693062 DOI: 10.1016/j.parkreldis.2008.06.005  0.32
2008 Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 2129-70. PMID 19025984 DOI: 10.1002/mds.22340  0.32
2008 Mainous AG, Smith DW, Geesey ME, Tilley BC. Factors influencing physician referrals of patients to clinical trials. Journal of the National Medical Association. 100: 1298-303. PMID 19024226  0.32
2008 Carlozzi NE, Horner MD, Yang C, Tilley BC. Factor analysis of the Repeatable Battery for the Assessment of Neuropsychological Status. Applied Neuropsychology. 15: 274-9. PMID 19023744 DOI: 10.1080/09084280802325124  0.32
2008 Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, Tilley BC. Caffeine and progression of Parkinson disease. Clinical Neuropharmacology. 31: 189-96. PMID 18670242 DOI: 10.1097/WNF.0b013e31815a3f03  0.32
2008 Kieburtz K, Tilley B, Ravina B, Galpern W, Shannon K, Tanner C, Wooten GF. A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-Month results Clinical Neuropharmacology. 31: 141-150. PMID 18520981 DOI: 10.1097/WNF.0b013e3181342f32  0.32
2008 Magwood GS, Zapka J, Jenkins C. A review of systematic reviews evaluating diabetes interventions: focus on quality of life and disparities. The Diabetes Educator. 34: 242-65. PMID 18375775 DOI: 10.1177/0145721708316551  0.32
2007 Gonsalves WC, Gessey ME, Mainous AG, Tilley BC. A study of lower extremity amputation rates in older diabetic South Carolinians. Journal of the South Carolina Medical Association (1975). 103: 4-7. PMID 17763819  0.32
2007 Moreno-John G, Fleming C, Ford ME, Lichtenberg P, Mangione CM, Pérez-Stable EJ, Tilley B, Washington OGM, Carrasquillo O. Mentoring in community-based participatory research: The RCMAR experience Ethnicity and Disease. 17: S1-33-S1-43. PMID 17598315  0.32
2007 Mainous AG, Koopman RJ, Diaz VA, Everett CJ, Wilson PW, Tilley BC. A coronary heart disease risk score based on patient-reported information. The American Journal of Cardiology. 99: 1236-41. PMID 17478150 DOI: 10.1016/j.amjcard.2006.12.035  0.32
2007 McQueen A, Vernon SW, Myers RE, Watts BG, Lee ES, Tilley BC. Correlates and predictors of colorectal cancer screening among male automotive workers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 500-9. PMID 17372245 DOI: 10.1158/1055-9965.EPI-06-0757  0.32
2007 Elm JJ, Kamp C, Tilley BC, Guimaraes P, Fraser D, Deppen P, Brocht A, Weaver C, Bennett S. Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 822-7. PMID 17357141 DOI: 10.1002/mds.21409  0.32
2007 Tilley BC, Galpern WR. Screening potential therapies: lessons learned from new paradigms used in Parkinson disease. Stroke; a Journal of Cerebral Circulation. 38: 800-3. PMID 17261742 DOI: 10.1161/01.STR.0000255227.96365.37  0.32
2007 Kieburtz K, Ravina B, Galpern WR, Tilley B, Shannon K, Tanner C, Wooten GF, Hamill R, Sage JI, Kosa E, Watts RL, Stover NR, McMurray R, Lew MF, Kawai C, et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease Neurology. 68: 20-28. PMID 17200487 DOI: 10.1212/01.wnl.0000250355.28474.8e  0.32
2007 Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 41-7. PMID 17115387 DOI: 10.1002/mds.21198  0.32
2006 Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke; a Journal of Cerebral Circulation. 37: 2508-13. PMID 16960091 DOI: 10.1161/01.STR.0000242290.01174.9e  0.32
2006 Pavlakis SG, Sacco R, Levine SR, Meschia JF, Palesch Y, Tilley BC, Adams HP. Lessons from adult stroke trials. Pediatric Neurology. 34: 446-9. PMID 16765822 DOI: 10.1016/j.pediatrneurol.2005.09.010  0.32
2006 Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke; a Journal of Cerebral Circulation. 37: 1798-804. PMID 16763191 DOI: 10.1161/01.STR.0000226897.43749.27  0.32
2006 Mainous AG, Smith DW, Geesey ME, Tilley BC. Development of a measure to assess patient trust in medical researchers. Annals of Family Medicine. 4: 247-52. PMID 16735527 DOI: 10.1370/afm.541  0.32
2006 Mainous AG, Baker R, Majeed A, Koopman RJ, Everett CJ, Saxena S, Tilley BC. English language skills and diabetes and hypertension among foreign-born South Asian adults in England. Public Health Reports (Washington, D.C. : 1974). 121: 331-6. PMID 16640158  0.32
2006 Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K, Wooten GF, Tanner CM, Goetz GC. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 66: 628-33. PMID 16534099 DOI: 10.1212/01.wnl.0000201251.33253.fb  0.32
2006 Nietert PJ, Mitchell HC, Bolster MB, Shaftman SR, Tilley BC, Silver RM. Racial variation in clinical and immunological manifestations of systemic sclerosis. The Journal of Rheumatology. 33: 263-8. PMID 16465656  0.32
2006 Mainous AG, Majeed A, Koopman RJ, Baker R, Everett CJ, Tilley BC, Diaz VA. Acculturation and diabetes among Hispanics: evidence from the 1999-2002 National Health and Nutrition Examination Survey. Public Health Reports (Washington, D.C. : 1974). 121: 60-6. PMID 16416699  0.32
2005 Libman R, Kwiakowski T, Lyden P, Grotta JC, Tilley BC, Fagen SC, Levine SR, Broderick JP, Lin Y, Lewandowski C, Frankel MR. Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 14: 50-4. PMID 17904000 DOI: 10.1016/j.jstrokecerebrovasdis.2004.11.002  0.32
2005 Guimaraes P, Kieburtz K, Goetz CG, Elm JJ, Palesch YY, Huang P, Ravina B, Tanner CM, Tilley BC. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clinical Trials (London, England). 2: 509-18. PMID 16422311 DOI: 10.1191/1740774505cn125oa  0.32
2005 Palesch YY, Tilley BC, Sackett DL, Johnston KC, Woolson R. Applying a phase II futility study design to therapeutic stroke trials. Stroke; a Journal of Cerebral Circulation. 36: 2410-4. PMID 16224086 DOI: 10.1161/01.STR.0000185718.26377.07  0.32
2005 Nietert PJ, Silver RM, Mitchell HC, Shaftman SR, Tilley BC. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. The Journal of Rheumatology. 32: 1888-92. PMID 16206342  0.32
2005 Levine SR, Broderick JP, Brott T, DeGraba T, Fagan SC, Frankel MR, Grotta JC, Haley EC, Hamilton S, Kwiatkowski T, Lewandowski CA, Lin Y, Libman R, Lu M, Lyden P, ... ... Tilley BC, et al. Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience Annals of Emergency Medicine. 46: 243-252. PMID 16126134 DOI: 10.1016/j.annemergmed.2005.02.013  0.32
2005 Huang P, Tilley BC, Woolson RF, Lipsitz S. Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem. Biometrics. 61: 532-9. PMID 16011701 DOI: 10.1111/j.1541-0420.2005.00322.x  0.32
2005 Mainous AG, Cheng AY, Garr RC, Tilley BC, Everett CJ, McKee MD. Nonprescribed antimicrobial drugs in Latino community, South Carolina. Emerging Infectious Diseases. 11: 883-8. PMID 15963283 DOI: 10.3201/eid1106.040960  0.32
2005 Kwiatkowski T, Libman R, Tilley BC, Lewandowski C, Grotta JC, Lyden P, Levine SR, Brott T. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Annals of Emergency Medicine. 45: 377-84. PMID 15795715 DOI: 10.1016/j.annemergmed.2004.06.021  0.32
2005 Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K. A responsive outcome for Parkinson's disease neuroprotection futility studies. Annals of Neurology. 57: 197-203. PMID 15668964 DOI: 10.1002/ana.20361  0.32
2005 Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. The Journal of Rheumatology. 32: 51-7. PMID 15630725  0.32
2005 Carter RE, Lipsitz SR, Tilley BC. Quasi-likelihood estimation for relative risk regression models. Biostatistics (Oxford, England). 6: 39-44. PMID 15618526 DOI: 10.1093/biostatistics/kxh016  0.32
2004 Onitilo AA, Lin YH, Okonofua EC, Afrin LB, Ariail J, Tilley BC. Race, education, and knowledge of bone marrow registry: Indicators of willingness to donate bone marrow among African Americans and Caucasians Transplantation Proceedings. 36: 3212-3219. PMID 15686731 DOI: 10.1016/j.transproceed.2004.10.019  0.32
2004 Palesch YY, Tilley BC. An efficient multi-stage, single-arm Phase II futility design for ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 55-6. PMID 15512874 DOI: 10.1080/17434470410020003  0.32
2004 Blixen CE, Bramstedt KA, Hammel JP, Tilley BC. A pilot study of health education via a nurse-run telephone self-management programme for elderly people with osteoarthritis. Journal of Telemedicine and Telecare. 10: 44-9. PMID 15006216 DOI: 10.1258/135763304322764194  0.32
2004 Pillemer SR, Tilley B. Clinical trials, outcome measures, and response criteria. The Journal of Rheumatology. 31: 407-10. PMID 14994378  0.32
2004 Lackland DT, Lin Y, Tilley BC, Egan BM. An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. Journal of Clinical Hypertension (Greenwich, Conn.). 6: 26-31; quiz 32-3. PMID 14724421  0.32
2003 Tanne D, Levine SR, Brey RL, Lin H, Tilley BC. Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial Neurology. 61: 1158-1159. PMID 14581697  0.32
2003 Higashida R, Furlan A, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. Journal of Vascular and Interventional Radiology : Jvir. 14: S493-4. PMID 14514864  0.32
2003 Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke; a Journal of Cerebral Circulation. 34: e109-37. PMID 12869717 DOI: 10.1161/01.STR.0000082721.62796.09  0.32
2003 Watts BG, Vernon SW, Myers RE, Tilley BC. Intention to be screened over time for colorectal cancer in male automotive workers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 339-49. PMID 12692109  0.32
2003 Ford ME, Havstad SL, Tilley BC. Recruiting older African American men to a cancer screening trial (the AAMEN Project). The Gerontologist. 43: 27-35. PMID 12604743  0.32
2003 Pillemer S, Gulko P, Ligier S, Yarboro C, Gourley M, Goldbach-Mansky R, Siegel R, Hirsch R, Pucino F, Tilley B, Wilder RL. Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis. The Journal of Rheumatology. 30: 41-3. PMID 12508388  0.32
2002 Wisdom K, Neighbors K, Williams VH, Havstad SL, Tilley BC. Recruitment of African Americans with type 2 diabetes to a randomized controlled trial using three sources. Ethnicity & Health. 7: 267-78. PMID 12772546 DOI: 10.1080/1355785022000060727  0.32
2002 Ford ME, Havstad SL, Brooks BL, Tilley BC. Perceptions of diabetes among patients in an urban health care system. Ethnicity & Health. 7: 243-54. PMID 12772544 DOI: 10.1080/1355785022000060709  0.32
2002 Tilley BC, Elm JJ. Improving health outcomes in diverse and vulnerable populations: building on the experience of the Centers for Medical Treatment Effectiveness in Diverse Populations (MEDTEP). Ethnicity & Health. 7: 227-30. PMID 12772542 DOI: 10.1080/1355785022000060682  0.32
2002 Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 59: 669-74. PMID 12221155  0.32
2002 Liao Y, Hawthorne V, Kozarevic D, Vojvodic N, Gillis C, Hole D, Hart C, Jorgensen T, Thomsen T, Selmer R, Tverdal A, Sigurdsson E, Goldbourt U, Yaari S, Froom P, ... ... Tilley B, et al. Prediction of mortality from coronary heart disease among diverse populations: Is there a common predictive function? Heart. 88: 222-228. PMID 12181209  0.32
2002 Fiorelli M, Von Kummer R, Levine SR, Tilley BC. Early ischemic changes on computed tomography in patients with acute stroke [3] Journal of the American Medical Association. 287: 2361-2362. PMID 11988052  0.32
2002 Bath P, Fisher M, Tilley BC. Re: Stroke therapy academic industry roundtable II (STAIR-II) [2] (multiple letters) Stroke. 33: 639-640. PMID 11833547  0.32
2001 Patel SC, Levine SR, Tilley BC, Grotta JC, Lu M, Frankel M, Haley EC, Brott TG, Broderick JP, Horowitz S, Lyden PD, Lewandowski CA, Marler JR, Welch KM. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. Jama. 286: 2830-8. PMID 11735758  0.32
2001 Lu M, Tilley BC. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: Data from the NINDS t-PA stroke trial Statistics in Medicine. 20: 1891-1901. PMID 11427947 DOI: 10.1002/sim.841  0.32
2001 Broderick J, Lu M, Jackson C, Pancioli A, Tilley BC, Fagan SC, Kothari R, Levine SR, Marler JR, Lyden PD, Haley EC, Brott T, Grotta JC. Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke. Annals of Neurology. 49: 736-44. PMID 11409425 DOI: 10.1002/ana.1058  0.32
2001 Vernon SW, Myers RE, Tilley BC, Li S. Factors associated with perceived risk in automotive employees at increased risk of colorectal cancer Cancer Epidemiology Biomarkers and Prevention. 10: 35-43. PMID 11205487  0.32
2000 Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC, Lewandowski CA, Kwiatkowski TP. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 55: 1649-55. PMID 11113218  0.32
2000 Frankel MR, Morgenstern LB, Kwiatkowski T, Lu M, Tilley BC, Broderick JP, Libman R, Levine SR, Brott T. Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA stroke trial Neurology. 55: 952-959. PMID 11061250  0.32
2000 Broderick JP, Lu M, Kothari R, Levine SR, Lyden PD, Haley EC, Brott TG, Grotta J, Tilley BC, Marler JR, Frankel M. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke; a Journal of Cerebral Circulation. 31: 2335-41. PMID 11022060  0.32
2000 Kristal AR, Glanz K, Tilley BC, Li S. Mediating factors in dietary change: Understanding the impact of a worksite nutrition intervention Health Education and Behavior. 27: 112-125. PMID 10709796  0.32
2000 Lafata JE, Tilley B, Nerenz D. Considerations in deciding when and how to evaluate provider group interventions Health Services and Outcomes Research Methodology. 1: 49-62. DOI: 10.1023/A:1010097804596  0.32
1999 Tilley BC, Pillemer SR, Heyse SP, Li S, Clegg DO, Alarcón GS. Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials Arthritis and Rheumatism. 42: 1879-1888. PMID 10513802 DOI: 10.1002/1529-0131(199909)42:9<1879::AID-ANR12>3.0.CO;2-1  0.32
1999 McDonald PE, Tilley BC, Havstad SL. Nurses' perceptions: Issues that arise in caring for patients with diabetes Journal of Advanced Nursing. 30: 425-430. PMID 10457245 DOI: 10.1046/j.1365-2648.1999.01096.x  0.32
1999 Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, Brott TG, Haley EC, Lyden PD, Kothari R, Frankel M, Lewandowski CA, Libman R, Kwiatkowski T, Broderick JP, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke; a Journal of Cerebral Circulation. 30: 1528-33. PMID 10436095  0.32
1999 Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. The New England Journal of Medicine. 340: 1781-7. PMID 10362821 DOI: 10.1056/NEJM199906103402302  0.32
1999 Alarcón GS, Tilley BC, Li S, Fowler SE, Pillemer SR. Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis Journal of Rheumatology. 26: 1065-1067. PMID 10332969  0.32
1999 Blixen CE, Havstad S, Tilley BC, Zoratti E. A comparison of asthma-related healthcare use between African-Americans and Caucasians belonging to a health maintenance organization (HMO) Journal of Asthma. 36: 195-204. PMID 10227271  0.32
1999 Broderick JP, Adams HP, Barsan W, Feinberg W, Feldmann E, Grotta J, Kase C, Krieger D, Mayberg M, Tilley B, Zabramski JM, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for Health Professionals from a Special Writing Group of the Stroke Council, American Heart Association Stroke. 30: 905-915. PMID 10187901  0.32
1999 Tilley BC, Glanz K, Kristal AR, Hirst K, Li S, Vernon SW, Myers R. Nutrition intervention for high-risk auto workers: Results of the next step trial Preventive Medicine. 28: 284-292. PMID 10072747 DOI: 10.1006/pmed.1998.0439  0.32
1999 Tilley BC, Vernon SW, Myers R, Glanz K, Lu M, Hirst K, Kristal AR. The next step trial: Impact of a worksite colorectal cancer screening promotion program Preventive Medicine. 28: 276-283. PMID 10072746 DOI: 10.1006/pmed.1998.0427  0.32
1999 Borzak S, Joseph C, Havstad S, Tilley B, Smith ST, Housholder SD, Gheorghiade M. Lower thrombolytic use for African Americans with myocardial infarction: an influence of clinical presentation? American Heart Journal. 137: 338-45. PMID 9924169 DOI: 10.1053/hj.1999.v137.92523  0.32
1998 Brott T, Lu M, Kothari R, Fagan SC, Frankel M, Grotta JC, Broderick J, Kwiatkowski T, Lewandowski C, Haley EC, Marler JR, Tilley BC. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke; a Journal of Cerebral Circulation. 29: 1504-9. PMID 9707184  0.32
1998 Ford ME, Tilley BC, McDonald PE. Social support among African-American adults with diabetes, part 2: A review Journal of the National Medical Association. 90: 425-432. PMID 9685778  0.32
1998 Ford ME, Tilley BC, McDonald PE. Social support among African-American adults with diabetes, Part 1: Theoretical framework Journal of the National Medical Association. 90: 361-365. PMID 9640907  0.32
1998 Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marler JR, Levine SR, Broderick JP, Kwiatkowski TG, Frankel M, Brott TG, Walker MD. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology. 50: 883-90. PMID 9566367  0.32
1998 Joseph CLM, Havstad SL, Ownby DR, Johnson CC, Tilley BC. Racial differences in emergency department use persist despite allergist visits and prescriptions filled for antiinflammatory medications Journal of Allergy and Clinical Immunology. 101: 484-490. PMID 9564801 DOI: 10.1016/S0091-6749(98)70355-0  0.32
Show low-probability matches.